Article metrics

Download PDFPDF
Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen

 

Online download statistics by month:

Online download statistics by month: August 2018 to December 2019

AbstractFullPdf
Aug 2018162911
Sep 201859410963
Oct 20183093415
Nov 20181972610
Dec 2018625225
Jan 20195412715
Feb 2019835204
Mar 201994352
Apr 201991773
May 2019940119
Jun 20197224931
Jul 20194757955
Aug 20191553717
Sep 201972265
Oct 201990203
Nov 2019195185
Dec 2019300207
Total8072519260